Live from the NIH registry
Studies recruiting near Athens right now
Top 25 of 75 recruiting studies, sorted by proximity — each links to its official registry page
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: NRG Oncology
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
Summit Clinical Research, LLC — Athens, Georgia (0.9 mi)
· Sponsor: Vedanta Biosciences, Inc.
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Atrial Fibrillation (AF)
N/A
Interventional 423 participants sought
Piedmont Heart of Athens — Athens, Georgia (0.9 mi)
· Sponsor: Vektor Medical
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Northeast Georgia Medical Center Braselton — Braselton, Georgia (25.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Changes in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women
Sleep Quality, Compliance
N/A
Interventional 36 participants sought
Physical Activity Measurement Lab — Athens, Georgia (0.9 mi)
· Sponsor: University of Georgia
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 3
Interventional 840 participants sought
Research Site — Athens, Georgia (0.9 mi)
· Sponsor: AstraZeneca
Harnessing Communication Preferences
Intellectual Disability, Autism Spectrum Disorder
N/A
Interventional 60 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: Joel E. Ringdahl
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Infectious Disease Consultants of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alcohol Use Disorder
Alcohol Use Disorder (AUD)
N/A
Interventional 30 participants sought
Project Adam — Winder, Georgia (20.3 mi)
· Sponsor: University of Georgia
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
Atrial Fibrillation (AF), Persistant Atrial Fibrillation
N/A
Interventional 699 participants sought
Piedmont Athens Regional — Athens, Georgia (0.9 mi)
· Sponsor: Boston Scientific Corporation
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Phase 1, Phase 2
Interventional 500 participants sought
University Cancer and Blood Center — Athens, Georgia (0.9 mi)
· Sponsor: Turning Point Therapeutics, Inc.
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Northeast Georgia Medical Center Braselton — Braselton, Georgia (25.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Metastatic Non-small Cell Lung Cancer
Phase 3
Interventional 744 participants sought
Research Site — Athens, Georgia (0.9 mi)
· Sponsor: AstraZeneca
Steps Towards Osteoarthritis Prevention
Anterior Cruciate Ligament Injuries
N/A
Interventional 56 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Georgia
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
University Cancer & Blood Center (UCBC) - Athens — Athens, Georgia (0.9 mi)
· Sponsor: Mirati Therapeutics Inc.
Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures
Blood Loss, Surgical
N/A
Interventional 40 participants sought
University Surgical Vascular — Watkinsville, Georgia (6.5 mi)
· Sponsor: University Surgical Vascular
Prospective Study to Assess a Diagnostic Aid for Cancer
Cancer
N/A
Observational 2,450 participants sought
Pulmonary & Sleep Specialists of Northeast Georgia, P.C — Winder, Georgia (20.3 mi)
· Sponsor: Harbinger Health
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 150 participants sought
University Cancer & Blood Center /ID# 270969 — Athens, Georgia (0.9 mi)
· Sponsor: AbbVie
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Pulmonary Hypertension Associated With HFpEF
Phase 3
Interventional 540 participants sought
Tenax Investigational Site — Athens, Georgia (0.9 mi)
· Sponsor: Tenax Therapeutics, Inc.
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma
Phase 1, Phase 2
Interventional 380 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: BioNTech SE
Mom Multi Postnatal Supplementation Trial
Postnatal Care
N/A
Interventional 80 participants sought
UGA Clinical & Translational Unit — Athens, Georgia (0.9 mi)
· Sponsor: Perelel Inc.
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma
N/A
Observational 800 participants sought
Northeast Georgia Medical Center Braselton — Braselton, Georgia (25.1 mi)
· Sponsor: University of Rochester
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: National Cancer Institute (NCI)
Dyadic Financial Incentive Treatments for Dual Smoker Couples
Smoking, Cigarette
Phase 2
Interventional 900 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Oklahoma
Intermittent Cottonseed Oil Consumption
Dyslipidemia, Overweight and Obesity
N/A
Interventional 75 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Georgia